Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing
Sunshine Biopharma announced a 1-for-20 reverse stock split effective at market open on October 26, 2026. The split is explicitly intended to regain compliance with Nasdaq's minimum bid price requirement, cutting shares outstanding from 15,219,383 to roughly 760,969.
Key figures
- Effective date
- October 26, 2026
- Reverse split ratio
- 1-for-20
- Shares outstanding after
- 760969
- Shares outstanding before
- 15219383
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.